Ovarian CancerInfo Center

A Heart Rx That Could Help Cancer Patients

Beta blockers are a class of heart medications that treat high blood pressure. But for some patients, they may have other lifesaving benefits.

Chemo Before Surgery May Benefit Ovarian Cancer Patients

It's not always one or the other when it comes to cancer treatment options like chemotherapy and surgery. And which comes first may make a difference.

Advice for Smarter, Cost-Saving Cancer Screening

Catching cancer early can save lives, but screening too often — without good reason — may be costly and harmful.

Cancer Survival Gains Not the Same for All Groups

Cancer patients are winning the battle against the disease like never before, but age and race may play a role in determining survival odds.

Common Menopause Therapy May Raise Cancer Risk

Hormone replacement therapy (HRT) is used by millions of women to treat menopause. HRT, however, has been shown to pose health risks, including increasing the chances of getting ovarian cancer.

Cancer Screening May Benefit Diabetes Patients

Diabetes patients may need to take extra precautions to lower their risk for cancer or catch it early.

Avastin Gets FDA Approval for New Use

The US Food and Drug Administration (FDA) has approved a new use for the cancer medication Avastin (bevacizumab), according to biotechnology company Genentech.

Call for Genetic Screening to Become New Norm

Gene mutations associated with higher rates of breast and ovarian cancer may pose a serious risk to Ashkenazi Jewish (AJ) women, even those without a family history of cancer. This prompted a call for more genetic cancer screening.

Using Ovarian Tumor Type to Predict Rx Benefit

Customizing treatments based on a patient’s genetics has led to more effective cancer treatments. Now, researchers have reported using ovarian cancer tumor types to predict how much one medication might benefit patients.

Rx Combo Showed Promise for Ovarian Cancer

Ovarian cancer is the second most common cancer of the female reproductive organs. It's common for this cancer to return after initial treatment, but two therapies used together may help fight this cancer.